A new technology to safely start heart rhythm medications at home using smartwatches
Official title: A novel, smartwatch-enabled, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home
Funded at Safebeat Rx INC. · NIH-10921676 · Data updated 2026-11-12
This study is testing a new smartwatch system that helps people with atrial fibrillation start their heart medication safely at home, so they can monitor their heart health and stay in touch with their doctors without needing to go to the hospital.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Safebeat Rx INC. NIH-funded |
| Lab location | 1 site (Carson, UNITED STATES) |
| Project start | September 17, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $295,153 |
| NIH project number | 1R43HL174305-01 |
| Project ID | NIH-10921676 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with atrial fibrillation who require antiarrhythmic medications and are considered low-risk for complications.
✕Less likely to help
Patients with high-risk atrial fibrillation or those who have contraindications to antiarrhythmic medications may not benefit from this research.
What this research studies
This research focuses on developing a smartwatch-enabled system that allows patients with atrial fibrillation to safely initiate antiarrhythmic medications from home. The technology monitors heart rhythms and analyzes ECG data using a machine learning algorithm to ensure that medication dosages are adjusted based on individual responses. By eliminating the need for hospitalization during the initial medication phase, this approach aims to improve access to essential treatments while minimizing risks associated with heart rhythm changes. Patients will be able to track their heart health and communicate with their physicians remotely.
Why it matters
Potential benefit: If successful, this research could enable patients to start life-saving heart rhythm medications safely at home, reducing hospital visits and improving treatment accessibility.
How similar studies have gone: Similar approaches using remote monitoring and mobile health technologies have shown promise in improving patient outcomes in other cardiovascular conditions, indicating potential success for this novel method.
Where this research is happening
-
Safebeat Rx INC.
Carson, United States Active
Researchers
- Principal investigator: Navara, Rachita — Safebeat Rx INC.
- Study coordinator: Navara, Rachita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.